HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marjolijn N Lub-de Hooge Selected Research

zirconium-89-trastuzumab

8/201489Zr-trastuzumab and 89Zr-bevacizumab PET to evaluate the effect of the HSP90 inhibitor NVP-AUY922 in metastatic breast cancer patients.
6/2013Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake.
2/2012Zirconium-89-trastuzumab positron emission tomography as a tool to solve a clinical dilemma in a patient with breast cancer.
6/2009Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marjolijn N Lub-de Hooge Research Topics

Disease

54Neoplasms (Cancer)
11/2022 - 07/2007
11Breast Neoplasms (Breast Cancer)
04/2021 - 09/2004
4Bites and Stings (Sting)
04/2021 - 01/2016
4Ovarian Neoplasms (Ovarian Cancer)
04/2016 - 03/2009
2Renal Cell Carcinoma (Grawitz Tumor)
01/2017 - 01/2015
2Disease Progression
01/2017 - 01/2015
2Amyloidosis
06/2007 - 04/2006
1Lymphoma (Lymphomas)
06/2020
1Adenocarcinoma
01/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2017
1Colorectal Neoplasms (Colorectal Cancer)
01/2016
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2016
1Leukemia
01/2016
1von Hippel-Lindau Disease (von Hippel Lindau Disease)
01/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2015
1Glioma (Gliomas)
09/2015
1Invasive Candidiasis
11/2014
1Triple Negative Breast Neoplasms
09/2014
1Neuroendocrine Tumors (Neuroendocrine Tumor)
07/2014
1Prostatic Neoplasms (Prostate Cancer)
10/2013

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2008
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2017 - 08/2007
1189Zr-bevacizumabIBA
01/2017 - 08/2007
9Pharmaceutical PreparationsIBA
01/2018 - 01/2008
8Monoclonal AntibodiesIBA
10/2017 - 09/2004
6Zirconium-89IBA
04/2021 - 07/2014
6Biomarkers (Surrogate Marker)IBA
11/2018 - 01/2008
6Bevacizumab (Avastin)FDA Link
01/2017 - 08/2007
5ErbB Receptors (EGF Receptor)IBA
10/2017 - 07/2010
4MesothelinIBA
11/2022 - 12/2015
4AntibodiesIBA
01/2019 - 01/2008
4zirconium-89-trastuzumabIBA
08/2014 - 06/2009
4Trastuzumab (Herceptin)FDA Link
01/2014 - 09/2004
3AntigensIBA
04/2021 - 12/2015
3LigandsIBA
01/2021 - 08/2017
3Epithelial Cell Adhesion MoleculeIBA
11/2020 - 07/2007
3Fluorescent Dyes (Fluorescent Probes)IBA
10/2018 - 01/2016
3human ERBB2 proteinIBA
11/2017 - 09/2004
3EverolimusFDA Link
01/2017 - 11/2012
3Transforming Growth Factors (Transforming Growth Factor)IBA
09/2015 - 12/2011
3Immunoglobulin G (IgG)IBA
12/2011 - 09/2004
2Peptides (Polypeptides)IBA
10/2021 - 10/2013
2Bispecific AntibodiesIBA
01/2020 - 01/2019
2Carcinoembryonic AntigenIBA
01/2019 - 10/2018
2Immunoglobulin FragmentsIBA
01/2018 - 01/2008
2Tyrosine Kinase InhibitorsIBA
11/2017 - 08/2017
2Lapatinib (GW572016)FDA Link
11/2017 - 11/2012
2lumretuzumabIBA
10/2017 - 07/2014
2Indicators and Reagents (Reagents)IBA
01/2017 - 06/2007
2Immunoconjugates (Immunoconjugate)IBA
04/2016 - 12/2015
2IRDye 800CWIBA
01/2016 - 12/2015
2fresolimumabIBA
09/2015 - 12/2011
2Protein Isoforms (Isoforms)IBA
09/2015 - 12/2011
2Sunitinib (Sutent)FDA Link
01/2015 - 01/2011
25- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
08/2014 - 05/2010
2ImmunosorbentsIBA
07/2013 - 05/2010
2EnzymesIBA
07/2013 - 05/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2013 - 08/2007
2Cisplatin (Platino)FDA LinkGeneric
05/2010 - 03/2009
2Serum Amyloid P-ComponentIBA
06/2007 - 04/2006
1Chelating AgentsIBA
11/2022
1Peptide Hydrolases (Proteases)FDA Link
10/2021
1AZD 6244IBA
12/2020
1BMS-986192IBA
12/2020
1IsotopesIBA
11/2020
1pembrolizumabIBA
10/2020
1Radioactive TracersIBA
06/2020
1bispecific antibody ERY974IBA
01/2020
1GlypicansIBA
01/2020
1EpitopesIBA
01/2019
1Programmed Cell Death 1 ReceptorIBA
12/2018
1atezolizumabIBA
12/2018
1Immune Checkpoint InhibitorsIBA
12/2018
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2018
1Therapeutic UsesIBA
01/2018
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
08/2017
1onartuzumabIBA
08/2017
1Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2017
189Zr-MSB0010853IBA
01/2017
1Differentiation AntigensIBA
12/2015
1InterferonsIBA
01/2015
1Antifungal AgentsIBA
11/2014
1Fluconazole (Zonal)FDA LinkGeneric
11/2014
1Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2014
1Insulin-Like PeptidesIBA
09/2014
1Estrogen ReceptorsIBA
08/2014
1Dihydrotachysterol (AT 10)IBA
04/2014
1PRS-110IBA
04/2014
1Technetium (Technetium 99m)IBA
10/2013
1Bombesin Receptors (Bombesin Receptor)IBA
10/2013
1RadiopharmaceuticalsIBA
10/2013
1BombesinIBA
10/2013
1bombesin (7-14)IBA
10/2013
1tricineIBA
10/2013

Therapy/Procedure

11Therapeutics
11/2022 - 12/2007
5Immunotherapy
01/2021 - 05/2007
3Intravenous Administration
01/2016 - 03/2009
1Precision Medicine
01/2017
1Radiotherapy
10/2013
1Prostatectomy (Retropubic Prostatectomy)
10/2013